Toni M. Whitaker, MD, professor of Pediatrics and chief of the Division of Developmental Pediatrics in the College of Medicine at the University of Tennessee Health Science Center (UTHSC) and Le Bonheur Children’s Hospital, has received a $94,000 grant from the Centers for Disease Control and Prevention (CDC) and the Association of University Centers on… Read More
Researchers from the University of Tennessee Health Science Center have received a $500,000 grant over three years from the Department of Defense to test a novel strategy using mitochondria transplantation therapy for restoration of neuromuscular structure and function after injury.
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.” March 16: Bioengineer March 16: News-Medical
As research into genetic causes of disease began to grow, Le Bonheur Pediatrician-in- Chief Jon McCullers, MD, knew it was time to start building a pediatric DNA biorepository. So in 2015, Le Bonheur’s Children’s Foundation Research Institute (CFRI) created the Biorepository and Integrative Genomics (BIG) Initiative and began collecting DNA samples from hospitalized children at… Read More
The National Heart, Lung, and Blood Institute recently awarded Jonathan H. Jaggar, PhD, Maury Bronstein Endowed Professor in the Department of Physiology at the University of Tennessee Health Science Center (UTHSC), a $2.3 million grant for his study titled “PKD proteins in endothelial cells.” The proposal’s goal is to provide a new understanding of how… Read More
The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia. Francesca-Fang Liao, PhD, and Fu-Ming Zhou, PhD, both professors in the Department of Pharmacology, Addiction Science, and Toxicology, are co-investigators on the project titled “Blood-brain-barrier… Read More
Understanding the molecular biology of brain tumors is key to prognosis and treatment said Le Bonheur Neuroscience Institute Co-Director Frederick Boop, MD, in his presentation “How Molecular Biology Impacts Clinical Practice” at the International Society for Pediatric Neurosurgery (ISPN) 2020 Virtual Meeting.
Thirumalini Vaithianathan, PhD, assistant professor in the Department of Pharmacology, Addiction Science, and Toxicology at the University of Tennessee Health Science Center, has spent a decade studying molecular signaling involved in vision. She has just received $1.9 million from the National Eye Institute for her project titled, “Dynamics of calcium signals control neurotransmitter release in… Read More